TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2195345

Group type: EXPERIMENTAL
Intervention: Topical cyclosporine (100 mg/ml, 5 ml, three times daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Vehicle (after switch to cyclosporine)
Number of subjects: 16
Study: 31919134

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (taxane and anthracycline)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Residual cancer after neoadjuvant chemotherapy
Number of subjects: 29
Study: 30850828

Group type: EXPERIMENTAL
Intervention: Basal diet + 100 mg MEF/kg diet
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Basal diet + 300 mg ECOS/kg diet
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Basal diet + 100 mg MEF/kg diet + 300 mg ECOS/kg diet
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Basal diet + 500 mg ECOS/kg diet
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Basal diet + 100 mg MEF/kg diet + 500 mg ECOS/kg diet
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group, basal diet
Number of subjects: 180
Study: 28052513

Group type: EXPERIMENTAL
Intervention: Project: EVO™ (n = 12)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Problem Solving Therapy (PST, n = 10)
Number of subjects: 22
Study: 25734997

Group type: EXPERIMENTAL
Intervention: PainCOACH (automated Internet-based pain coping skills training)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 113
Study: 23871679

Group type: EXPERIMENTAL
Intervention: Progesterone (1mg/kg per 12h for 5 days)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (no progesterone)
Number of subjects: 76
Study: 21707926

Group type: EXPERIMENTAL
Intervention: Gepirone-ER (40-80 mg/day)
Number of subjects: 334
Study: 19486255

Group type: EXPERIMENTAL
Intervention: TACE-IFN (interferon-alpha1b at a dose of 3 million units three times a week for 48 weeks)
Number of subjects: 216

Group type: COMPARATOR
Intervention: TACE (transarterial chemoembolization alone)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: TACE-IFN
Number of subjects: 216

Group type: COMPARATOR
Intervention: TACE
Number of subjects: 216
Study: 17029616

Group type: EXPERIMENTAL
Intervention: Noninvasive models using HBV DNA levels, alkaline phosphatase, albumin, and platelet counts
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Noninvasive models using age, HBV DNA levels, AST, and albumin
Number of subjects: 276

Group type: COMPARATOR
Intervention: AST
Number of subjects: 276
Study: 12941996

Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg
Number of subjects: 690

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 690
Study: 11579890

Group type: EXPERIMENTAL
Intervention: Atovaquone-proguanil (1 tablet daily for 7 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9631219

Group type: EXPERIMENTAL
Intervention: Soccer players
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 29
Study: 7880659

Group type: EXPERIMENTAL
Intervention: Clonidine 5 micrograms kg‐1 and famotidine 20 mg (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (famotidine 20 mg) (n = 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 2835200

Group type: EXPERIMENTAL
Intervention: Conventional prazosin (2 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oros prazosin (5.5 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29909377

Group type: EXPERIMENTAL
Intervention: Aspirin (81 or 100 mg daily)
Number of subjects: 2536

Group type: COMPARATOR
Intervention: No aspirin
Number of subjects: 2536
Study: 27041480

Group type: EXPERIMENTAL
Intervention: Candesartan at a dose of 16 mg per day plus hydrochlorothiazide at a dose of 12.5 mg per day
Number of subjects: 12705

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12705
Study: 23642462

Group type: EXPERIMENTAL
Intervention: Olanzapine plus sertraline
Number of subjects: 259

Group type: COMPARATOR
Intervention: Olanzapine plus placebo
Number of subjects: 259
Study: 23735519

Group type: EXPERIMENTAL
Intervention: Amantadine hydrochloride (200 to 400mg daily for 4 weeks)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo (daily for 4 weeks)
Number of subjects: 184
Study: 20582594

Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 800

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 800
Study: 18670333

Group type: EXPERIMENTAL
Intervention: Medial branch blocks with bupivacaine (nonsteroid group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cervical medial branch blocks with bupivacaine and steroid (steroid group)
Number of subjects: 120
Study: 16855125

Group type: EXPERIMENTAL
Intervention: Tailored decision aid
Number of subjects: 131

Group type: COMPARATOR
Intervention: General educational pamphlet
Number of subjects: 131
Study: 12941993

Group type: EXPERIMENTAL
Intervention: Low-dose combined angiotensin-converting enzyme inhibitor and calcium channel blocker antihypertensive treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two preselected, fixed-dose combination therapies
Number of subjects: 0
Study: 11517995

Group type: EXPERIMENTAL
Intervention: Acetylcholinesterase inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 0
Study: 9215092

Group type: EXPERIMENTAL
Intervention: Valaciclovir 500 mg twice daily
Number of subjects: 739

Group type: COMPARATOR
Intervention: Aciclovir 200 mg five times daily
Number of subjects: 739
Study: 8203335

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg three times daily
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg three times daily
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225
Study: 3311120

Group type: EXPERIMENTAL
Intervention: Codeine (30 mg four times daily)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Promethazine (25 mg four times daily)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Comparison of Codeine and Promethazine
Number of subjects: 11
Study: 31181131

Group type: EXPERIMENTAL
Intervention: FFS group (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: CAP group (n = 25)
Number of subjects: 50
Study: 28099499

Group type: EXPERIMENTAL
Intervention: Experimental Formula (EF) with bovine MFGM concentrate
Number of subjects: 240

Group type: COMPARATOR
Intervention: Standard Formula (SF)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Breast-fed Reference (BFR)
Number of subjects: 240
Study: 25864939

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg single dose)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 23894731

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 743
Study: 21266929

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg·kg(‐1))
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 10
Study: 19702708

Group type: EXPERIMENTAL
Intervention: Tisseel fibrin glue
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vicryl sutures
Number of subjects: 50
Study: 17225370

Group type: EXPERIMENTAL
Intervention: Home-based CR (home-CR)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Traditional CR (trad-CR)
Number of subjects: 61
Study: 15514503

Group type: EXPERIMENTAL
Intervention: FIO2 0.26
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: FIO2 0.60
Number of subjects: 19

Group type: COMPARATOR
Intervention: FIO2 0.21 (control)
Number of subjects: 19
Study: 11133611

Group type: EXPERIMENTAL
Intervention: 30% Oxygen group
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 80% Oxygen group
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Ondansetron group
Number of subjects: 240
Study: 9624028

Group type: EXPERIMENTAL
Intervention: Short-acting antibiotics for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Short-acting antibiotics for 8 to 10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long course of short-acting antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceftriaxone or azithromycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-acting antibiotics
Number of subjects: 0
Study: 7911624

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide under hydrocolloid dressing (Duoderm E)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Triamcinolone acetonide monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrocolloid dressing monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Triamcinolone acetonide under plastic occlusion (Opsite IV 3000)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrocolloid dressing (Duoderm E)
Number of subjects: 0
Study: 2912014

Group type: EXPERIMENTAL
Intervention: Low-fat, restricted (R) diet (800 kcal)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Exercise (X)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Nonexercise (NX)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low-fat, ad libitum-carbohydrate (AL) diet
Number of subjects: 26
Study: 1093603

Group type: EXPERIMENTAL
Intervention: Method 2: Open drainage with primary suture and pelvic peritoneal floor reconstituted
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Method 3: Primary suture with unsutured pelvic peritoneal floor
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control: Open drainage
Number of subjects: 106
Study: 31536837

Group type: EXPERIMENTAL
Intervention: 1 g of TXA for every 1000 mL of the distending medium
Number of subjects: 80

Group type: COMPARATOR
Intervention: 10 mL of placebo (10 mL of 1.5% glycine) in the same form inside every 1000 mL of the distention medium
Number of subjects: 80
Study: 31557812

Group type: EXPERIMENTAL
Intervention: Polar M400 use and twice‐weekly social cognitive theory‐ and self‐determination theory‐based Facebook‐delivered health education intervention
Number of subjects: 38

Group type: COMPARATOR
Intervention: Enrollment only in separate, but content‐identical, Facebook intervention
Number of subjects: 38
Study: 29101095

Group type: EXPERIMENTAL
Intervention: Smartphone CBT app (Kokoro-app) in addition to medication change
Number of subjects: 164
Study: 26477119

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost per quality-adjusted life year
Number of subjects: 0
Study: 23619509

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Cognitive tests
Number of subjects: 246
Study: 21991727

Group type: EXPERIMENTAL
Intervention: 2 mg/kg tramadol (group T, n = 35)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 1 mg/kg lidocaine 2% (group L, n = 35)
Number of subjects: 70
Study: 18951624

Group type: EXPERIMENTAL
Intervention: High phonetic combinability characters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High consistency characters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High combinability or high consistency characters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phonetic consistency effects
Number of subjects: 0
Study: 16762079

Group type: EXPERIMENTAL
Intervention: Modular care involving individualised modules with choice, goal-setting, and coaching
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional care as directed by the participant's doctors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Contemporary reference group attending CR
Number of subjects: 0
Study: 14973336

Group type: EXPERIMENTAL
Intervention: Augmented feedback of the obtained trajectories on a computer screen in real time
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal vision
Number of subjects: 0
Study: 11322206

Group type: EXPERIMENTAL
Intervention: 10 MU IFN daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: 5 MU twice-daily
Number of subjects: 24
Study: 9196668

Group type: EXPERIMENTAL
Intervention: Inter-ocular temporal asynchrony (IOTA) system
Number of subjects: 28

Group type: COMPARATOR
Intervention: Monocular neutral density filters
Number of subjects: 28
Study: 8646870

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate cream, 0.05%
Number of subjects: 100

Group type: COMPARATOR
Intervention: Betamethasone valerate cream, 0.1%
Number of subjects: 100
Study: 2258448

Group type: EXPERIMENTAL
Intervention: Fenfluramine 40‐120 mg/day
Number of subjects: 15

Group type: COMPARATOR
Intervention: Desipramine (control)
Number of subjects: 15
Study: 7416558

Group type: EXPERIMENTAL
Intervention: Terbutaline 2.5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Theophylline 130 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combination of Theophylline 130 mg and Terbutaline 2.5 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31918748

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 84
Study: 30694211

Group type: EXPERIMENTAL
Intervention: Structured exercise training (SET)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Foot exercises activating calf muscles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 0
Study: 28382660

Group type: EXPERIMENTAL
Intervention: Threshold inspiratory muscle training (5 sessions per week, 21-30 min per session, over 8 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (medical treatment and routine care only, without intervention)
Number of subjects: 55
Study: 26424607

Group type: EXPERIMENTAL
Intervention: Scheduling plus appointment text message reminders
Number of subjects: 2054

Group type: COMPARATOR
Intervention: Appointment text message reminder-only
Number of subjects: 2054

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2054

Group type: EXPERIMENTAL
Intervention: Scheduling plus appointment text message reminders (for children without a baseline appointment)
Number of subjects: 2054

Group type: COMPARATOR
Intervention: Appointment text message reminder-only (for children without a baseline appointment)
Number of subjects: 2054

Group type: COMPARATOR
Intervention: Usual care (for children without a baseline appointment)
Number of subjects: 2054
Study: 24656175

Group type: EXPERIMENTAL
Intervention: JE-CV
Number of subjects: 8
Study: 21822980

Group type: EXPERIMENTAL
Intervention: Psychological intervention
Number of subjects: 114

Group type: COMPARATOR
Intervention: Health education session
Number of subjects: 114
Study: 20864724

Group type: EXPERIMENTAL
Intervention: Intervention with FOBT kit
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Intervention without FOBT kit
Number of subjects: 548

Group type: COMPARATOR
Intervention: Control group (education on physical activity)
Number of subjects: 548
Study: 18614727

Group type: EXPERIMENTAL
Intervention: Bolus tube feeding (6.93 ± 0.38 MJ/d of 4.18 kJ/mL multinutrient feed)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo boluses (<0.4 MJ/d)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bolus tube feeding
Number of subjects: 6
Study: 16094059

Group type: EXPERIMENTAL
Intervention: Comprehensive lifestyle changes
Number of subjects: 93

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 93
Study: 12108334

Group type: EXPERIMENTAL
Intervention: Intravenous interleukin-2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interferon alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of interleukin-2 and interferon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subgroup of patients with >70% probability of progression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: s.c. cytokine regimens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Overall survival
Number of subjects: 0
Study: 10774700

Group type: EXPERIMENTAL
Intervention: Dilazep
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 8646822

Group type: EXPERIMENTAL
Intervention: Erythromycin (400 mg orally three times a day for 10 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (matched placebo given orally three times a day for 10 days)
Number of subjects: 12
Study: 1475039

Group type: EXPERIMENTAL
Intervention: 200 mg pyritinol dihydrochloride-monohydrate, 3 times daily for 12 weeks
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 6706234

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy (various modalities)
Number of subjects: 656

Group type: COMPARATOR
Intervention: No further treatment after primary surgery
Number of subjects: 656

Group type: COMPARATOR
Intervention: Tumors of borderline malignancy or stage Ia(i) well-differentiated tumors
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Clear cell carcinoma
Number of subjects: 656
Study: 30635064

Group type: EXPERIMENTAL
Intervention: Meditative intervention commencing two weeks before surgery for four weeks post-surgery
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Meditative intervention commencing from the day after surgery for four weeks post-surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard of care with no meditative intervention
Number of subjects: 40
Study: 30063162

Group type: EXPERIMENTAL
Intervention: Guardian Connect system (mobile device with software application)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Guardian Link 3 transmitter (Glucose Sensor Recorder)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Overall results for both systems
Number of subjects: 145
Study: 25427553

Group type: EXPERIMENTAL
Intervention: Conservative treatment without reduction of the fracture
Number of subjects: 85

Group type: COMPARATOR
Intervention: Closed reduction and bouquet pinning
Number of subjects: 85
Study: 23769752

Group type: EXPERIMENTAL
Intervention: Educational brochure mailed to families prior to VCUG
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (no educational brochure)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 105
Study: 21283007

Group type: EXPERIMENTAL
Intervention: β-blocker therapy
Number of subjects: 1327
Study: 18763027

Group type: EXPERIMENTAL
Intervention: etanercept 50 mg twice weekly
Number of subjects: 30

Group type: COMPARATOR
Intervention: acitretin 0.4 mg/kg per day
Number of subjects: 30
Study: 17367446

Group type: EXPERIMENTAL
Intervention: Parenteral testosterone (Sustanon 250 intramuscular injection)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg orally daily
Number of subjects: 13
Study: 15303278

Group type: EXPERIMENTAL
Intervention: Gene expression profiles in cardiac myocytes with normal sinus rhythm
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Weighted-distance method for arrhythmia prediction
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Calculation formulae for left ventricular ejection fraction
Number of subjects: 17
Study: 11580123

Group type: EXPERIMENTAL
Intervention: Pedicle screw fixation
Number of subjects: 130

Group type: COMPARATOR
Intervention: Uninstrumented fusion
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups (pedicle screw fixation and uninstrumented fusion)
Number of subjects: 130
Study: 8229622

Group type: EXPERIMENTAL
Intervention: Counter-rotational powered brush (CRPB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control oral hygiene methods
Number of subjects: 40
Study: 3543347

Group type: EXPERIMENTAL
Intervention: Lateral paramedian incision
Number of subjects: 431

Group type: COMPARATOR
Intervention: Midline incision
Number of subjects: 431
Study: 31938803

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 30400784

Group type: EXPERIMENTAL
Intervention: Internet-based physical activity promotion program (6-month access)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internet-based physical activity promotion program plus physiotherapy counselling (remote support)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care with a leaflet containing physical activity guidelines
Number of subjects: 0
Study: 26463007

Group type: EXPERIMENTAL
Intervention: L-epinephrine plus dexamethasone
Number of subjects: 174

Group type: COMPARATOR
Intervention: Dexamethasone (Control)
Number of subjects: 174
Study: 25551810

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fascia iliaca compartment block (FICB)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 3 in 1 block
Number of subjects: 70

Group type: COMPARATOR
Intervention: No block (Control group)
Number of subjects: 70
Study: 23545863

Group type: EXPERIMENTAL
Intervention: Levosimendan 0.1 μg/kg/min
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 20724766

Group type: EXPERIMENTAL
Intervention: Nigella sativa
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 30
Study: 18446781

Group type: EXPERIMENTAL
Intervention: Early closure (EC; 8 days)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Late closure (LC; 2 months)
Number of subjects: 186
Study: 16354143

Group type: EXPERIMENTAL
Intervention: Teaching module with guided discussion and practice highlighting use of a mnemonic
Number of subjects: 43

Group type: COMPARATOR
Intervention: General discussion and provision of the mnemonic at the end of the session
Number of subjects: 43
Study: 14568987

Group type: EXPERIMENTAL
Intervention: High-dose etoposide, ifosfamide, and cisplatin (VIP) chemotherapy plus autologous stem cell support, administered in one cycle followed by three to four sequential cycles every 3 weeks.
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: High-dose VIP chemotherapy with stem cell support.
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Dose level 6 of high-dose VIP (cisplatin 100 mg/m2, etoposide 1500 mg/m2, ifosfamide 10 g/m2) recommended for further investigation.
Number of subjects: 221
Study: 10910864

Group type: EXPERIMENTAL
Intervention: Amsorb (A; Armstrong Medical, Coleraine, Northern Ireland)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drägersorb 800 Plus (D; Dräger, Luebeck, Germany)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medisorb (M; Datex‐Ohmeda, Bromma, Sweden)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drägersorb 800 (C)
Number of subjects: 0
Study: 8877265

Group type: EXPERIMENTAL
Intervention: Electrophysiologic Study
Number of subjects: 0

Group type: COMPARATOR
Intervention: Holter Monitoring
Number of subjects: 0